BiotechTube
Home/DeepCure/Luca Rastelli
LR

Luca Rastelli

Chief Scientific Officer

DeepCure

Therapeutic Areas

Autoimmune DiseasesInflammatory DiseasesImmunology

DeepCure Pipeline

DrugIndicationPhase
DC-9476 (BRD4-BD2 inhibitor)Rheumatoid Arthritis, Still's Disease, Hidradenitis SuppurativaIND-Enabling
DC-15442 (STAT6 inhibitor)Asthma, Atopic DermatitisIND-Enabling
TNFα programAuto-immune indicationsEarly Discovery

Leadership Team at DeepCure

KS
Kfir Schreiber
CEO & Co-Founder
T(
Thrasyvoulos (Thras) Karydis
CTO & Co-Founder
HL
Han Lim
Chief Business Officer
JJ
Joseph Jacobson
Co-Founder
View full DeepCure profile